{"gene":"E2F4","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1994,"finding":"E2F4 associates with p107 in vivo (co-immunoprecipitation), requires DP-1 for efficient DNA binding and transcriptional activation of E2F site-containing promoters, and lacks nuclear localization signal leading to distinct subcellular distribution compared to E2F-1.","method":"Co-immunoprecipitation, transient transfection reporter assays, cell cycle analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and functional reporter assays independently replicated in two simultaneous papers (PMID:7958925 and PMID:7958924)","pmids":["7958925","7958924"],"is_preprint":false},{"year":1994,"finding":"E2F4 forms heterodimers with DP family members, and p107 binding suppresses E2F4 transcriptional activity and its ability to transform immortalized rodent cells.","method":"Yeast two-hybrid, Co-IP, focus-formation/transformation assays, reporter gene assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (two-hybrid, Co-IP, functional transformation assay) in two independent labs","pmids":["7958924","7958925"],"is_preprint":false},{"year":1995,"finding":"E2F4 interacts with p130 in a yeast two-hybrid system and forms differentially phosphorylated complexes with p130 throughout the cell cycle; E2F4 is present throughout the cell cycle unlike E2F-1/-2/-3.","method":"Yeast two-hybrid, Co-immunoprecipitation, Western blot","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid plus Co-IP, confirmed in two independent simultaneous publications","pmids":["7892279","7705662"],"is_preprint":false},{"year":1995,"finding":"p130 effectively suppresses E2F4-mediated transactivation, and coexpression of E2F4 overcomes p130-mediated G1 arrest more efficiently than RB-induced G1 blockade, revealing biochemically distinct mechanisms for p130 versus RB in cell cycle arrest.","method":"Transient transfection, reporter assays, cell cycle analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple functional assays with clear mechanistic distinction between p130 and RB pathways","pmids":["7705662"],"is_preprint":false},{"year":1995,"finding":"p130-E2F4 complexes occupy the cdc2 promoter at a non-canonical E2F site located at position -20 in quiescent cells (G0/G1), and release of this complex at S phase entry correlates with cdc2 induction; mutation of the -20 element de-represses cdc2 in quiescent cells.","method":"In vivo footprinting, Co-IP, transient transfection with promoter mutants","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo footprinting combined with promoter mutagenesis and functional reporter assays in a single rigorous study","pmids":["8524257"],"is_preprint":false},{"year":1996,"finding":"E2F4 switches pocket protein partners in a cell cycle-dependent manner: it is sequestered by p130 in arrested/quiescent cells but associates with both pRB and p107 as cells pass the G1-to-S transition; E2F4 accounts for the vast majority of endogenous E2F activity.","method":"Specific antisera immunoprecipitation, cell cycle fractionation, EMSA","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic cell-cycle fractionation with specific antisera, multiple cell-cycle stages analyzed","pmids":["8657117"],"is_preprint":false},{"year":1996,"finding":"During G1-to-G0 transition, p130 undergoes CDK-independent phosphorylation (form 2) that promotes p130-E2F4 complex formation characteristic of G0; subsequent CDK-mediated hyperphosphorylation (form 3) in mid-G1 dissociates E2F4 from p130.","method":"Cell cycle synchronization, Western blot, in vitro kinase assay with cyclin/CDK","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro CDK phosphorylation reconstitution combined with cell cycle biochemistry in one study","pmids":["8710362"],"is_preprint":false},{"year":1997,"finding":"E2F4 subcellular localization is cell cycle-dependent: it is predominantly cytoplasmic when ectopically expressed, but nuclear localization is induced by cotransfection of p107, p130, or DP-2 (but not DP-1); nuclear E2F4 shows markedly enhanced transcriptional activity, and endogenous E2F4 has high nuclear/cytoplasmic ratios in G0/early G1, shifting to more cytoplasmic as cells approach S phase.","method":"Immunofluorescence, subcellular fractionation, reporter assays, cell synchronization","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — live-cell localization, fractionation, and functional reporter assays combined with cell cycle analysis","pmids":["9144196"],"is_preprint":false},{"year":1998,"finding":"E2F4 lacks a nuclear localization signal and requires cytoplasmic binding partners (p107, pRb2/p130, or the NLS-containing DP3δ isoform) to enter the nucleus; nuclear accumulation via p107 or p130 correlates with growth arrest, whereas E2F4/DP3δ-induced cell cycle reactivation is counteracted by p107 or p130 overexpression.","method":"Immunoprecipitation, subcellular fractionation, cotransfection, cell cycle analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic dissection of NLS requirement with multiple domain mutants and functional rescue experiments","pmids":["9537223"],"is_preprint":false},{"year":2000,"finding":"E2F4 is actively exported from the nucleus in a CRM1-dependent manner via two hydrophobic nuclear export sequences; mutation of both export signals prevents cytoplasmic localization, and CRM1 overexpression can prevent p16INK4a-induced cell cycle arrest (an E2F4-dependent process).","method":"Leptomycin B treatment, export sequence mutagenesis, CRM1 overexpression, cell cycle analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — pharmacological inhibition of export combined with mutagenesis of export signals and functional cell cycle readout","pmids":["11158323"],"is_preprint":false},{"year":2000,"finding":"E2F4 and E2F5 double knockout mouse embryonic fibroblasts fail to arrest in G1 in response to p16INK4a, demonstrating that E2F4 and E2F5 are dispensable for cell cycle progression per se but are necessary for pocket protein-mediated G1 arrest of cycling cells.","method":"Double knockout mouse model, MEF isolation, cell cycle analysis, p16INK4a challenge","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic double knockout with specific cellular phenotype and mechanistic pathway placement","pmids":["11030352"],"is_preprint":false},{"year":2000,"finding":"Loss of E2F4 in mice causes a cell-autonomous defect in late-stage erythroid maturation and abnormalities in hematopoietic lineage development, as well as gut epithelial defects, indicating E2F4 controls the maturation of multiple cell lineages.","method":"Knockout mouse model, histopathology, bone marrow analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — independently replicated by two separate knockout mouse studies in the same journal issue","pmids":["10983976","10983977"],"is_preprint":false},{"year":2000,"finding":"p130/E2F4 complex binds and represses the cdc2 promoter via the R box (positions -22 to -2) in response to p53; this repression requires p21/WAF1, which inhibits CDK activity, thereby facilitating p130 dephosphorylation and p130/E2F4 binding.","method":"Promoter reporter assays, EMSA, Co-IP, p21 antisense experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — EMSA, reporter assay, and genetic p21 requirement tested with multiple orthogonal approaches","pmids":["11032828"],"is_preprint":false},{"year":2002,"finding":"A preformed cytoplasmic complex containing Smad3, E2F4/5, DP1, and the corepressor p107 translocates to the nucleus in response to TGF-β, associates with Smad4, and binds a composite Smad-E2F site on the c-myc promoter to repress c-myc transcription.","method":"Co-immunoprecipitation, subcellular fractionation, ChIP, reporter assays, dominant-negative experiments","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (Co-IP, ChIP, fractionation, reporter assays) in one rigorous study with high impact","pmids":["12150994"],"is_preprint":false},{"year":2002,"finding":"E2F4 loss suppresses pituitary and thyroid tumor development in Rb+/- mice and suppresses inappropriate proliferation of pRB-deficient cells; biochemical analysis indicates this occurs because E2F4 loss allows p107 and p130 to regulate the pRB-specific activator E2Fs.","method":"Compound knockout mouse model, tumor monitoring, Western blot, cell proliferation assays","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis with biochemical mechanistic follow-up","pmids":["12498715"],"is_preprint":false},{"year":2002,"finding":"p130 requires at least nine phosphorylation sites (three Cdk4/6-specific plus six additional serines: S413, S639, S662, S1044, S1080, S1112) for full regulation of E2F4 activity and cell cycle control; p107 regulation of E2F4 requires its three Cdk4/6-specific sites only.","method":"Alanine substitution mutagenesis, E2F reporter assays, cell cycle analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic in vitro mutagenesis combined with functional reporter and cell cycle assays","pmids":["12006580"],"is_preprint":false},{"year":2003,"finding":"pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes occupy the ER-alpha promoter in vivo in ER-negative breast cancer cells, mediating transcriptional repression of ER-alpha.","method":"ChIP, Co-IP, in vivo promoter occupancy analysis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP in cell lines, single lab, two orthogonal methods","pmids":["12789259"],"is_preprint":false},{"year":2003,"finding":"The p16INK4a-RB pathway is blocked by EBV LMP1 in part through CRM1-dependent nuclear export of E2F4/5, preventing E2F4/5 from mediating p16INK4a-induced cell cycle arrest.","method":"Subcellular fractionation, leptomycin B treatment, cell cycle analysis, reporter assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition of CRM1 plus localization and functional assays","pmids":["12860972"],"is_preprint":false},{"year":2003,"finding":"E2F4 loss in mice prevents spontaneous adipocyte differentiation independently of changes in E2F-responsive gene expression or cell cycle regulation, and this anti-adipogenic function of E2F4 operates independently of its interaction with pocket proteins.","method":"Compound knockout MEF differentiation assays, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection in compound mutant MEFs separating cell cycle function from differentiation function","pmids":["12604789"],"is_preprint":false},{"year":2004,"finding":"Ionizing radiation increases E2F4 protein levels and promotes E2F4 nuclear accumulation and binding to p130 (but not p107) in prostate carcinoma cells via p130 dephosphorylation and dissociation from CDK2; siRNA knockdown of E2F4 prevents E2F4/p130 complex formation and sensitizes cells to radiation-induced apoptosis.","method":"Western blot, nuclear fractionation, Co-IP, siRNA knockdown, apoptosis assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA loss-of-function with specific apoptotic phenotype and mechanistic Co-IP, single lab","pmids":["15231644"],"is_preprint":false},{"year":2006,"finding":"E2f4 promotes fetal erythroid proliferation by directly activating cell cycle control genes; loss of E2f4 results in impaired cell cycle progression and decreased erythroid proliferation, causing macrocytic anemia.","method":"E2f4 knockout mouse model, cDNA microarray, cell cycle analysis, BrdU incorporation","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout mouse with microarray identification of direct targets and cell cycle phenotype","pmids":["16861343"],"is_preprint":false},{"year":2006,"finding":"Following radiation treatment, E2F4 colocalizes with p130 in the nucleus during G2-phase arrest and represses mitotic genes (Bub3, Pttg1) as identified by ChIP; siRNA knockdown of E2F4 sensitizes cells to radiation-induced DNA damage and cell death.","method":"Immunofluorescence, ChIP, siRNA knockdown, microarray, clonogenic survival assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter occupancy combined with siRNA loss-of-function and functional survival assay","pmids":["17043659"],"is_preprint":false},{"year":2006,"finding":"Host Cell Factor-1 (HCF-1) directly interacts with E2F4 via multiple determinants: E2F4 targets both the kelch domain (through its HBM tetrapeptide DHXY motif) and the basic domain of HCF-1; HCF-1 co-activates E2F4/DP-1 transcriptional activity.","method":"GST pulldown, Co-IP, mutagenesis, transient transfection reporter assays, temperature-sensitive HCF-1 rescue assay","journal":"Molecular and cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding confirmed by pulldown and Co-IP with mutagenesis, single lab","pmids":["16633736"],"is_preprint":false},{"year":2007,"finding":"The mammalian DREAM complex contains p130 and E2F4 (along with LIN-9, LIN-37, LIN-52, LIN-54, RBBP4) and binds to more than 800 human promoters in G0 to repress cell cycle-dependent genes; in S phase, MuvB proteins dissociate from p130 and form a distinct submodule with MYB.","method":"Affinity purification/mass spectrometry, ChIP-chip, RNAi knockdown, genome-wide promoter analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — proteomics-based complex identification combined with genome-wide ChIP-chip and functional RNAi in one integrated study","pmids":["17531812"],"is_preprint":false},{"year":2007,"finding":"Mip/LIN-9 forms a repressor complex with E2F4 and p107 or p130 in G0/early G1; phosphorylation of pocket proteins by CDK4 drives dissociation of Mip/LIN-9 from E2F4/p107/p130; expression of p107 blocks B-Myb/Mip/LIN-9-induced activation of the cyclin B promoter.","method":"Co-immunoprecipitation, reporter assays, cell cycle synchronization, CDK4 overexpression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and functional reporter assays, single lab","pmids":["17563750"],"is_preprint":false},{"year":2007,"finding":"E2f4 deficiency in mice leads to complete absence of ciliated cells from the airway epithelium and nasal sinuses, replaced by columnar secretory cells, and reduced Clara cell marker expression, demonstrating a cell-cycle-independent requirement of E2f4 in determining airway epithelial cell fate.","method":"E2f4 knockout mouse model, histology, immunohistochemistry, BrdU cell proliferation analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — well-characterized knockout phenotype with cell-proliferation controls ruling out indirect effects","pmids":["17383628"],"is_preprint":false},{"year":2007,"finding":"E2F4 deficiency in mice results in loss of ventral telencephalic structures and impaired neural precursor self-renewal associated with dramatic reduction in Shh expression; genetic interaction between E2F4 and Shh pathways was confirmed by compound heterozygous crosses and Hh agonist rescue.","method":"Knockout mouse model, genetic epistasis (compound heterozygous cross), Shh enhancer reporter assay, Hh agonist rescue","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic epistasis plus functional enhancer assay and pharmacological rescue","pmids":["17537963"],"is_preprint":false},{"year":2008,"finding":"TGF-β suppresses survivin expression in prostate epithelial cells via Smad2/3-dependent hypophosphorylation of Rb, which enables Rb/E2F4 repressor complexes to bind CDE/CHR repressor elements in the survivin promoter.","method":"Co-IP, ChIP, promoter reporter assays, viral overexpression/silencing of survivin","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with functional gene delivery experiments, single lab","pmids":["18504435"],"is_preprint":false},{"year":2009,"finding":"ARF disrupts the interaction between E2F4 and DP1, reducing occupancy of the E2F4-p130 repressor complex at the XPC promoter, thereby increasing XPC expression and enabling nucleotide excision repair; cells lacking ARF are NER-deficient and ARF expression restores repair.","method":"Co-IP, ChIP, genetic ARF knockout cells, NER functional assay","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and genetic loss-of-function with functional DNA repair readout","pmids":["19644500"],"is_preprint":false},{"year":2009,"finding":"E2F4 nuclear localization in intestinal cells is proliferation-dependent; cytoplasmic retention and sequestration by Rb proteins represent critical steps in cell cycle exit; inhibition of p38 MAP kinase induces E2F4 nuclear translocation and transcriptional activity.","method":"Subcellular fractionation, immunofluorescence, Ki67 co-staining, p38 inhibitor treatment","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway interrogation combined with localization and functional assays, single lab","pmids":["15040009","19562678"],"is_preprint":false},{"year":2010,"finding":"PARP inhibition causes increased occupancy of BRCA1 and RAD51 promoters by repressive E2F4/p130 complexes, leading to suppression of HDR; disruption of p130 by HPV E7 expression or siRNA knockdown reverses both the transcriptional repression and the cytotoxicity.","method":"ChIP, siRNA knockdown, GFP-based HDR assay, clonogenic survival","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP demonstrating direct promoter occupancy combined with genetic disruption of p130 and functional HDR assay","pmids":["20133863"],"is_preprint":false},{"year":2011,"finding":"E2F4 binding sites are present both near transcription start sites and at distal enhancer-like elements (>20 kb from annotated TSS); overexpression of E2F4 with RB family members and DP-1 reveals that E2F4 can act as both a transcriptional activator and a repressor.","method":"ChIP-seq, overexpression studies, functional reporter assays","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq combined with overexpression functional assays, single lab","pmids":["21247883"],"is_preprint":false},{"year":2011,"finding":"p27Kip1 directly interacts with p130 and E2F4 through its carboxy-half (demonstrated by affinity chromatography), is recruited to target promoters by p130, and is required for subsequent recruitment of HDAC and mSin3A to repress transcription.","method":"Co-IP, affinity chromatography, ChIP, luciferase reporter assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct binding by affinity chromatography plus ChIP, single lab","pmids":["22179826"],"is_preprint":false},{"year":2012,"finding":"KDM5A (H3K4 demethylase) co-occupies E2F4 target gene promoters; during ES cell differentiation, KDM5A and E2F4 cooperate to repress cell cycle genes, with p130 (DREAM component) also binding these targets in terminally differentiated cells; KDM5A is recruited independently of E2F4 but cooperates with E2F4 for deepened repression.","method":"ChIP-seq, KDM5A knockout ES cells, ChIP, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq combined with genetic knockout and functional differentiation experiments","pmids":["23093672"],"is_preprint":false},{"year":2012,"finding":"E2F4-p130 repressor complex directly represses transcription of apoptosis-related genes (E2F1, Apaf-1, p73α) in cardiomyocytes through HDAC1 recruitment; loss of E2F4 in vivo leads to enhanced cardiomyocyte apoptosis; HDAC-binding deficient p130 or kinase-dead HDAC1 mutants abolish the anti-apoptotic function.","method":"ChIP, E2F4 knockout mouse histology, dominant-negative HDAC1/p130 mutants, hypoxia apoptosis assay","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP combined with genetic knockout in vivo and domain-specific mutant functional assays","pmids":["22985930"],"is_preprint":false},{"year":2012,"finding":"p38MAPK phosphorylates E2F4 at Thr261/Thr263 residues in differentiating chick retinal neurons downstream of NGF/p75NTR signaling; phosphorylated E2F4 is recruited to the E2F-responsive cdc2 promoter to trigger cell cycle reentry and apoptosis; constitutively active E2F4-T261E/T263E mimics this, while dominant-negative T261A/T263A blocks NGF-induced reactivation.","method":"In vitro kinase assay, phospho-specific antibody, ChIP, constitutively active and dominant-negative E2F4 mutants, cell cycle analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro kinase assay combined with phospho-mutagenesis and ChIP demonstrating promoter recruitment","pmids":["22586272"],"is_preprint":false},{"year":2013,"finding":"p53-mediated repression of target genes (survivin, CDC25C, CDC25B) is mediated through p21-dependent recruitment of E2F4 repressor complexes to promoters; inactivation of RB pocket proteins (not RB alone) prevents E2F4 recruitment and gene repression; E2F4 promoter occupancy globally marks p53-repression targets but not p53-activation targets.","method":"ChIP, siRNA knockdown of pocket proteins, ChIP-seq integration, reporter assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP with genome-wide integration, genetic dissection of pocket protein requirement, multiple target genes validated","pmids":["24096481"],"is_preprint":false},{"year":2013,"finding":"MEK/ERK activation and GSK3 inhibition are both required for E2F4 phosphorylation, nuclear translocation, and G1/S phase entry in human intestinal epithelial cells; EGF activates ERK but fails to promote E2F4 nuclear translocation unless GSK3 is concomitantly inhibited.","method":"MEK inhibitor (U0126), GSK3 inhibitor (SB216763), phosphorylation analysis, immunofluorescence, cell cycle analysis","journal":"BMC cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological pathway dissection with multiple inhibitor combinations and localization readout, single lab","pmids":["23919615"],"is_preprint":false},{"year":2014,"finding":"E2F4 plays a protective role in neurons against ischemia/DNA damage by forming repressive complexes at the B-Myb promoter under basal conditions; following stress, E2F4-p130 complexes are lost from B-Myb promoter sites, B-Myb expression increases, and neuronal death ensues.","method":"ChIP, Co-IP, in vitro ischemia/hypoxia models, in vivo global ischemia model, E2F4 gain/loss-of-function","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating direct promoter occupancy combined with in vivo genetic and in vitro functional assays, single lab","pmids":["24828495"],"is_preprint":false},{"year":2017,"finding":"E2F4-RBL2(p130)-HDAC1-BRM(SWI/SNF) repressor complex assembles at the PARP1 promoter during differentiation-associated cell cycle exit, deacetylating nucleosomes and compacting chromatin to silence PARP1; HDAC inhibition restores PARP1 expression without disrupting complex-chromatin interaction.","method":"ChIP, Co-IP, HDAC inhibitor treatment, siRNA knockdown, chromatin accessibility analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with pharmacological and genetic perturbations, single lab","pmids":["28842672"],"is_preprint":false},{"year":2018,"finding":"Multicilin transcriptional activity in multiciliated cell (MCC) differentiation requires E2F4 as a co-activator; a fusion of E2F4 with the VP16 activation domain (E2F4VP16) in combination with Multicilin is sufficient to bypass the transcriptional block in primary fibroblasts and drive massive centriole expansion via the deuterosome pathway.","method":"Adenoviral overexpression in primary MEFs, centriole expansion quantification, temporal organelle biogenesis analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with activation domain fusion in non-natural cell type, single lab","pmids":["30120325"],"is_preprint":false},{"year":2019,"finding":"In mouse embryonic stem cells, E2F4 acts as a transcriptional activator of cell cycle genes independently of the RB family; E2F4 functionally interacts with chromatin regulators associated with gene activation, and loss of E2F4 in RB family-mutant cells decreases histone acetylation at E2F target gene promoters.","method":"E2F4 knockout in RB family triple-mutant ESCs, ChIP for histone acetylation, RNA-seq, proliferation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function in genetically defined RB-null background with epigenomic and transcriptomic readouts","pmids":["31270324"],"is_preprint":false},{"year":2022,"finding":"USP2 deubiquitinase stabilizes E2F4 protein through physical interaction and deubiquitination; stabilized E2F4 directly activates transcription of autophagy genes ATG2A and ULK2 to drive cytoprotective autophagy and zinc homeostasis in gastric cancer cells.","method":"Co-IP, GST pulldown, CHX chase/ubiquitination assays, ChIP, gain/loss-of-function studies, in vivo xenograft","journal":"Autophagy","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — deubiquitination biochemistry (Co-IP, ubiquitin assay, CHX chase) combined with ChIP of direct target promoters and in vivo rescue experiments","pmids":["35253629"],"is_preprint":false}],"current_model":"E2F4 is a transcription factor that lacks an intrinsic nuclear localization signal and shuttles between cytoplasm and nucleus in a cell cycle-dependent manner: in quiescent cells it is imported into the nucleus by binding to p130 (or p107/DP-2), where it forms multiprotein repressor complexes (including DREAM, which contains p130, LIN-9/37/52/54, and RBBP4) that silence hundreds of cell cycle-dependent target gene promoters; upon mitogenic stimulation, CDK-mediated hyperphosphorylation of p130/p107 dissociates these complexes, and E2F4 is actively exported from the nucleus via CRM1-dependent hydrophobic export sequences; beyond canonical G1 repression, E2F4/p130 complexes also maintain a stable G2 arrest in response to genotoxic stress by repressing mitotic genes, and E2F4 can act as a transcriptional activator of cell cycle genes in certain contexts (e.g., embryonic stem cells) independently of the RB family; post-translational regulation includes deubiquitination and stabilization by USP2, and phosphorylation by p38MAPK at Thr261/263 that promotes its recruitment to specific promoters; E2F4 also functions as a downstream effector of TGF-β signaling through a preformed cytoplasmic complex with Smad3/E2F4/DP1/p107 that translocates to the nucleus to repress c-myc."},"narrative":{"mechanistic_narrative":"E2F4 is a DP-heterodimerizing transcription factor that serves as the principal effector of pocket-protein-mediated transcriptional repression, silencing cell cycle-dependent genes in quiescent and arrested cells and accounting for the majority of endogenous E2F DNA-binding activity [PMID:7958925, PMID:7958924, PMID:8657117]. E2F4 lacks an intrinsic nuclear localization signal and depends on cytoplasmic binding to pocket proteins p130, p107, or pRB (or the NLS-bearing DP3δ isoform) for nuclear entry, where partner choice is cell cycle-dependent: p130 sequesters E2F4 in quiescence and is exchanged for pRB/p107 across the G1/S transition [PMID:8657117, PMID:9144196, PMID:9537223]. Nuclear residence is opposed by CRM1-dependent export through two hydrophobic export sequences, and CDK-driven hyperphosphorylation of p130/p107 dissociates the repressor complexes to permit S-phase gene induction [PMID:8710362, PMID:11158323, PMID:12006580]. In G0, E2F4/p130 nucleates the DREAM complex (with LIN-9/37/52/54 and RBBP4) that occupies more than 800 promoters, and assembles HDAC1-, mSin3A-, KDM5A-, and SWI/SNF-containing co-repressor modules that deacetylate and compact chromatin at target promoters such as cdc2, PARP1, and ER-alpha [PMID:17531812, PMID:12789259, PMID:22179826, PMID:23093672, PMID:28842672]. E2F4/p130 repression is integrated into multiple arrest and stress pathways: it executes p53/p21-dependent gene silencing, maintains genotoxic G2 arrest by repressing mitotic genes, suppresses BRCA1/RAD51 to limit homologous-directed repair, and functions downstream of TGF-β via a preformed cytoplasmic Smad3/E2F4/DP1/p107 complex that represses c-myc [PMID:11032828, PMID:24096481, PMID:17043659, PMID:20133863, PMID:12150994]. Genetically, E2F4 is dispensable for cell cycle progression itself but required for pocket-protein-mediated G1 arrest, and in vivo it controls maturation of erythroid, intestinal, airway-ciliated, and neural lineages, partly through cell-cycle-independent functions [PMID:11030352, PMID:10983976, PMID:10983977, PMID:16861343, PMID:17383628, PMID:17537963]. In RB-family-null embryonic stem cells E2F4 instead acts as a direct transcriptional activator of cell cycle genes, and post-translational inputs—USP2-mediated deubiquitination/stabilization and p38MAPK phosphorylation at Thr261/263—redirect E2F4 toward activation of autophagy or cell-cycle-reentry programs [PMID:31270324, PMID:35253629, PMID:22586272].","teleology":[{"year":1994,"claim":"Established E2F4 as a DP-dependent E2F-family transcription factor whose activity is constrained by the pocket protein p107, defining its core biochemical identity.","evidence":"Co-IP, yeast two-hybrid, reporter and focus-formation/transformation assays in rodent cells","pmids":["7958925","7958924"],"confidence":"High","gaps":["Did not establish the in vivo target gene set","NLS deficiency noted but mechanism of nuclear entry unresolved"]},{"year":1995,"claim":"Identified p130 as a cell-cycle-stage-specific E2F4 partner and showed p130 represses E2F4 transactivation through a mechanism biochemically distinct from RB, positioning E2F4/p130 at quiescence.","evidence":"Yeast two-hybrid, Co-IP, in vivo footprinting and promoter mutagenesis at the cdc2 promoter","pmids":["7892279","7705662","8524257"],"confidence":"High","gaps":["Genome-wide target scope unknown","Phosphorylation sites controlling complex assembly not yet defined"]},{"year":1996,"claim":"Showed E2F4 switches pocket-protein partners across the cell cycle and that p130 phosphorylation state governs complex assembly and dissociation, explaining temporal control of repression.","evidence":"Cell-cycle fractionation with specific antisera, EMSA, in vitro CDK kinase assays","pmids":["8657117","8710362"],"confidence":"High","gaps":["Precise p130 phosphosite requirements only later mapped","Did not address subcellular trafficking"]},{"year":1998,"claim":"Resolved how an NLS-less transcription factor reaches the nucleus, showing E2F4 is imported as a passenger of pocket proteins or the NLS-containing DP3δ isoform, coupling localization to growth arrest.","evidence":"Immunofluorescence, subcellular fractionation, cotransfection and cell-cycle analysis","pmids":["9144196","9537223"],"confidence":"High","gaps":["Mechanism of nuclear exit not yet defined","Endogenous stoichiometry of import partners unclear"]},{"year":2000,"claim":"Defined CRM1-dependent nuclear export via hydrophobic export signals as the counterbalance to partner-mediated import, and used genetics to show E2F4/E2F5 are required specifically for pocket-protein-mediated G1 arrest rather than cycling.","evidence":"Leptomycin B, export-signal mutagenesis, CRM1 overexpression, and E2F4/E2F5 double-knockout MEFs challenged with p16INK4a","pmids":["11158323","11030352"],"confidence":"High","gaps":["Signals that trigger export switching not fully mapped","Redundancy with E2F5 obscures E2F4-specific roles"]},{"year":2000,"claim":"Connected E2F4/p130 repression to the p53/p21 tumor-suppressor axis and revealed cell-autonomous developmental roles in hematopoietic, erythroid, and gut lineages.","evidence":"EMSA, reporter assays, p21 antisense, and knockout-mouse histopathology","pmids":["11032828","10983976","10983977"],"confidence":"High","gaps":["Direct vs indirect developmental targets not separated","Tissue-specific cofactors undefined"]},{"year":2002,"claim":"Placed E2F4 downstream of TGF-β via a preformed cytoplasmic Smad3/E2F4/DP1/p107 complex repressing c-myc, and established in vivo genetic epistasis showing E2F4 loss suppresses Rb-deficient tumorigenesis by freeing p107/p130 to regulate activator E2Fs.","evidence":"Co-IP, fractionation, ChIP, reporter assays, and Rb+/-;E2f4-/- compound mouse tumor models","pmids":["12150994","12498715","12006580"],"confidence":"High","gaps":["Generality of Smad-E2F coupling across TGF-β targets unclear","p130 phosphosite hierarchy tested in reporters not endogenous loci"]},{"year":2003,"claim":"Defined the chromatin-modifying machinery recruited by E2F4 repressor complexes (HDAC1, SUV39H1, DNMT1, p300) at the ER-alpha promoter and identified additional regulatory inputs through CRM1-dependent export hijacked by EBV LMP1.","evidence":"ChIP, Co-IP of multimolecular complexes, and viral oncoprotein/leptomycin B perturbation","pmids":["12789259","12860972"],"confidence":"Medium","gaps":["ER-alpha complex composition from a single cell-line study","Direct vs cooperative recruitment of each modifier not dissected"]},{"year":2003,"claim":"Demonstrated a pocket-protein-independent, cell-cycle-independent role for E2F4 in adipocyte differentiation, separating its differentiation functions from its canonical repressor activity.","evidence":"Compound-knockout MEF differentiation and gene-expression assays","pmids":["12604789"],"confidence":"High","gaps":["Molecular partner mediating the pocket-protein-independent function unidentified"]},{"year":2006,"claim":"Showed E2F4/p130 enforces a stable post-genotoxic G2 arrest by repressing mitotic genes and confirmed direct HCF-1 binding as a transcriptional co-activator input, while a knockout study revealed E2F4 directly activates cell cycle genes to drive fetal erythroid proliferation.","evidence":"ChIP, immunofluorescence, siRNA and clonogenic survival; GST pulldown/Co-IP for HCF-1; knockout-mouse microarray and BrdU","pmids":["17043659","16633736","16861343"],"confidence":"High","gaps":["How E2F4 toggles between repressor and activator at the same loci unclear","HCF-1 study single lab"]},{"year":2007,"claim":"Defined the DREAM complex at the molecular and genome-wide level, establishing E2F4/p130 with the MuvB module as the master quiescence repressor of >800 promoters, and extended E2F4 to cell-fate decisions in airway ciliated cells and ventral telencephalon via Shh.","evidence":"Affinity-purification/MS, ChIP-chip, RNAi; Co-IP for LIN-9; knockout-mouse histology and genetic Shh epistasis with agonist rescue","pmids":["17531812","17563750","17383628","17537963"],"confidence":"High","gaps":["Mechanism linking E2F4 to Shh transcription not fully resolved","Determinants of MuvB-to-MYB submodule switching incomplete"]},{"year":2009,"claim":"Linked E2F4/p130 repression to DNA repair regulation (XPC, NER) controlled by ARF disruption of the E2F4-DP1 interaction, and tied E2F4 nuclear localization in intestine to proliferation and p38 MAPK signaling.","evidence":"Co-IP, ChIP, ARF-knockout cells, NER assay; fractionation, Ki67 co-staining, p38 inhibition","pmids":["19644500","15040009","19562678"],"confidence":"High","gaps":["How ARF accesses the E2F4-DP1 interface mechanistically undefined","Intestinal p38 study single lab/Medium confidence"]},{"year":2010,"claim":"Demonstrated that E2F4/p130 represses homologous-recombination genes (BRCA1, RAD51), making the complex a determinant of PARP-inhibitor cytotoxicity.","evidence":"ChIP, siRNA, HPV E7 disruption of p130, GFP-HDR assay and clonogenic survival","pmids":["20133863"],"confidence":"High","gaps":["Signal coupling PARP inhibition to increased E2F4/p130 occupancy unresolved"]},{"year":2011,"claim":"Genome-wide mapping placed E2F4 at both promoters and distal enhancers and confirmed it can function as activator or repressor depending on cofactor context.","evidence":"ChIP-seq and overexpression reporter assays","pmids":["21247883"],"confidence":"Medium","gaps":["Context determinants of activation vs repression not defined","Single-lab genome-wide dataset"]},{"year":2012,"claim":"Identified KDM5A as a cooperating repressor at E2F4 targets during ES differentiation and showed E2F4/p130-HDAC1 directly represses pro-apoptotic genes in cardiomyocytes, defining tissue-specific cytoprotective repression.","evidence":"ChIP-seq with KDM5A knockout ESCs; ChIP, E2F4-knockout mouse heart, dominant-negative HDAC1/p130 mutants, hypoxia apoptosis","pmids":["23093672","22985930"],"confidence":"High","gaps":["Whether KDM5A and DREAM act sequentially or cooperatively unresolved","Cardiac target-gene generality limited"]},{"year":2012,"claim":"Showed p38MAPK phosphorylation of E2F4 at Thr261/263 converts it into a promoter-recruited driver of cell cycle reentry and apoptosis in differentiating neurons, defining a phosphorylation switch in E2F4 function.","evidence":"In vitro kinase assay, phospho-specific antibody, ChIP, phospho-mimetic/dead E2F4 mutants","pmids":["22586272"],"confidence":"High","gaps":["Whether Thr261/263 phosphorylation operates outside neuronal context untested"]},{"year":2013,"claim":"Established that p53/p21-dependent gene repression globally requires recruitment of E2F4 repressor complexes via pocket proteins, marking E2F4 occupancy as a signature of p53-repressed targets.","evidence":"ChIP, siRNA of pocket proteins, ChIP-seq integration, reporter assays; plus MEK/ERK+GSK3 control of E2F4 nuclear entry","pmids":["24096481","23919615"],"confidence":"High","gaps":["How p21-CDK inhibition selects specific E2F4 targets unclear","MEK/ERK-GSK3 study single lab/Medium confidence"]},{"year":2014,"claim":"Extended E2F4/p130 repression to neuroprotection through basal silencing of B-Myb, with stress-induced loss of occupancy driving neuronal death.","evidence":"ChIP, Co-IP, in vitro and in vivo ischemia models with E2F4 gain/loss-of-function","pmids":["24828495"],"confidence":"Medium","gaps":["Signal triggering complex eviction from B-Myb undefined","Single-lab study"]},{"year":2017,"claim":"Defined an E2F4-RBL2-HDAC1-BRM(SWI/SNF) complex that compacts chromatin to silence PARP1 during differentiation-associated cell cycle exit, detailing the chromatin-remodeling arm of repression.","evidence":"ChIP, Co-IP, HDAC inhibitor, siRNA, chromatin-accessibility analysis","pmids":["28842672"],"confidence":"Medium","gaps":["Order of HDAC vs SWI/SNF recruitment unresolved","Single-lab study"]},{"year":2018,"claim":"Identified E2F4 as a required co-activator for Multicilin-driven multiciliated-cell differentiation and centriole amplification, reinforcing an activator role in organelle biogenesis.","evidence":"Adenoviral E2F4 and E2F4-VP16 overexpression in primary fibroblasts with centriole quantification","pmids":["30120325"],"confidence":"Medium","gaps":["Endogenous activator mechanism vs VP16 fusion artifact not separated","Single-lab gain-of-function"]},{"year":2019,"claim":"Demonstrated in RB-family-null ESCs that E2F4 directly activates cell cycle genes and increases histone acetylation at their promoters, formally establishing an RB-independent activator function.","evidence":"E2F4 knockout in RB triple-mutant ESCs with ChIP for acetylation, RNA-seq, proliferation assays","pmids":["31270324"],"confidence":"High","gaps":["Identity of activating chromatin partners not fully resolved","Whether this occurs in RB-proficient cells unknown"]},{"year":2022,"claim":"Showed USP2 deubiquitinates and stabilizes E2F4, redirecting it to directly activate autophagy genes (ATG2A, ULK2) for cytoprotective autophagy in gastric cancer, linking E2F4 turnover to an activator output.","evidence":"Co-IP, GST pulldown, CHX chase/ubiquitination, ChIP, gain/loss-of-function, xenograft","pmids":["35253629"],"confidence":"High","gaps":["E3 ligase opposing USP2 on E2F4 unidentified","Whether autophagy activation generalizes beyond gastric cancer untested"]},{"year":null,"claim":"How E2F4 is selectively switched between its dominant repressor mode and context-specific activator mode at individual loci, and which cofactors and post-translational modifications dictate that choice, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating phosphorylation, ubiquitination, and cofactor identity in choosing activation vs repression","Activator partners largely uncharacterized relative to the well-defined repressor machinery"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,23,41]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,4,31]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[13,23]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,8,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,8,13]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[23,16]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[5,10,23]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[13,23,36]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,33,39]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[13,27]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[28,30]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[42]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[11,25,26,20]}],"complexes":["DREAM complex","Smad3/E2F4/DP1/p107 complex","E2F4-RBL2-HDAC1-BRM(SWI/SNF) complex"],"partners":["TFDP1","RBL2","RBL1","RB1","LIN9","SMAD3","USP2","HDAC1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q16254","full_name":"Transcription factor E2F4","aliases":[],"length_aa":413,"mass_kda":44.0,"function":"Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F4 binds with high affinity to RBL1 and RBL2. In some instances can also bind RB1. Specifically required for multiciliate cell differentiation: together with MCIDAS and E2F5, binds and activate genes required for centriole biogenesis","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q16254/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/E2F4","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/E2F4","total_profiled":1310},"omim":[{"mim_id":"621288","title":"LIN52 DREAM MUVB CORE COMPLEX COMPONENT; LIN52","url":"https://www.omim.org/entry/621288"},{"mim_id":"621287","title":"LIN37 DREAM MUVB CORE COMPLEX COMPONENT; LIN37","url":"https://www.omim.org/entry/621287"},{"mim_id":"621239","title":"INTEGRATOR COMPLEX SUBUNIT 15; INTS15","url":"https://www.omim.org/entry/621239"},{"mim_id":"619085","title":"PROGENITOR RENEWAL-ASSOCIATED NONCODING RNA; PRANCR","url":"https://www.omim.org/entry/619085"},{"mim_id":"617851","title":"SERTA DOMAIN-CONTAINING PROTEIN 2; SERTAD2","url":"https://www.omim.org/entry/617851"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/E2F4"},"hgnc":{"alias_symbol":["E2F-4"],"prev_symbol":[]},"alphafold":{"accession":"Q16254","domains":[{"cath_id":"1.10.10.10","chopping":"20-91","consensus_level":"high","plddt":81.9706,"start":20,"end":91},{"cath_id":"-","chopping":"140-171_180-195","consensus_level":"medium","plddt":92.0033,"start":140,"end":195}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16254","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q16254-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q16254-F1-predicted_aligned_error_v6.png","plddt_mean":64.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=E2F4","jax_strain_url":"https://www.jax.org/strain/search?query=E2F4"},"sequence":{"accession":"Q16254","fasta_url":"https://rest.uniprot.org/uniprotkb/Q16254.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q16254/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q16254"}},"corpus_meta":[{"pmid":"12150994","id":"PMC_12150994","title":"E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12150994","citation_count":399,"is_preprint":false},{"pmid":"7958925","id":"PMC_7958925","title":"E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7958925","citation_count":352,"is_preprint":false},{"pmid":"7958924","id":"PMC_7958924","title":"E2F-4, a new member of the E2F transcription factor family, interacts with p107.","date":"1994","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7958924","citation_count":345,"is_preprint":false},{"pmid":"17531812","id":"PMC_17531812","title":"Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.","date":"2007","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/17531812","citation_count":341,"is_preprint":false},{"pmid":"7892279","id":"PMC_7892279","title":"E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7892279","citation_count":326,"is_preprint":false},{"pmid":"8657117","id":"PMC_8657117","title":"E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8657117","citation_count":313,"is_preprint":false},{"pmid":"7705662","id":"PMC_7705662","title":"Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7705662","citation_count":305,"is_preprint":false},{"pmid":"11030352","id":"PMC_11030352","title":"E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11030352","citation_count":237,"is_preprint":false},{"pmid":"20133863","id":"PMC_20133863","title":"Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20133863","citation_count":173,"is_preprint":false},{"pmid":"17908821","id":"PMC_17908821","title":"A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.","date":"2007","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/17908821","citation_count":173,"is_preprint":false},{"pmid":"9144196","id":"PMC_9144196","title":"The subcellular localization of E2F-4 is cell-cycle dependent.","date":"1997","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9144196","citation_count":171,"is_preprint":false},{"pmid":"8524257","id":"PMC_8524257","title":"In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8524257","citation_count":165,"is_preprint":false},{"pmid":"10983976","id":"PMC_10983976","title":"E2F4 is essential for normal erythrocyte maturation and neonatal viability.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10983976","citation_count":155,"is_preprint":false},{"pmid":"10983977","id":"PMC_10983977","title":"Loss of E2F4 activity leads to abnormal development of multiple cellular lineages.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10983977","citation_count":137,"is_preprint":false},{"pmid":"21247883","id":"PMC_21247883","title":"Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21247883","citation_count":123,"is_preprint":false},{"pmid":"10991938","id":"PMC_10991938","title":"A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10991938","citation_count":122,"is_preprint":false},{"pmid":"9192806","id":"PMC_9192806","title":"Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.","date":"1997","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9192806","citation_count":115,"is_preprint":false},{"pmid":"12789259","id":"PMC_12789259","title":"pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12789259","citation_count":113,"is_preprint":false},{"pmid":"12498715","id":"PMC_12498715","title":"E2F4 loss suppresses tumorigenesis in Rb mutant mice.","date":"2002","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/12498715","citation_count":109,"is_preprint":false},{"pmid":"31391118","id":"PMC_31391118","title":"Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31391118","citation_count":106,"is_preprint":false},{"pmid":"17563750","id":"PMC_17563750","title":"Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17563750","citation_count":99,"is_preprint":false},{"pmid":"11032828","id":"PMC_11032828","title":"p130/E2F4 binds to and represses the cdc2 promoter in response to p53.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11032828","citation_count":93,"is_preprint":false},{"pmid":"27753528","id":"PMC_27753528","title":"Novel functions for the transcription factor E2F4 in development and disease.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/27753528","citation_count":92,"is_preprint":false},{"pmid":"10867026","id":"PMC_10867026","title":"Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10867026","citation_count":92,"is_preprint":false},{"pmid":"11158323","id":"PMC_11158323","title":"E2F4 is exported from the nucleus in a CRM1-dependent manner.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11158323","citation_count":89,"is_preprint":false},{"pmid":"8710362","id":"PMC_8710362","title":"G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8710362","citation_count":84,"is_preprint":false},{"pmid":"12860972","id":"PMC_12860972","title":"Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12860972","citation_count":83,"is_preprint":false},{"pmid":"10779331","id":"PMC_10779331","title":"E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10779331","citation_count":83,"is_preprint":false},{"pmid":"24096481","id":"PMC_24096481","title":"p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/24096481","citation_count":80,"is_preprint":false},{"pmid":"28987387","id":"PMC_28987387","title":"MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28987387","citation_count":80,"is_preprint":false},{"pmid":"15718499","id":"PMC_15718499","title":"Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15718499","citation_count":73,"is_preprint":false},{"pmid":"23093672","id":"PMC_23093672","title":"Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23093672","citation_count":71,"is_preprint":false},{"pmid":"16861343","id":"PMC_16861343","title":"E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation.","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16861343","citation_count":71,"is_preprint":false},{"pmid":"19562678","id":"PMC_19562678","title":"E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.","date":"2009","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19562678","citation_count":67,"is_preprint":false},{"pmid":"12006580","id":"PMC_12006580","title":"Distinct phosphorylation events regulate p130- and p107-mediated repression of E2F-4.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12006580","citation_count":67,"is_preprint":false},{"pmid":"22179826","id":"PMC_22179826","title":"p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/22179826","citation_count":66,"is_preprint":false},{"pmid":"8723352","id":"PMC_8723352","title":"E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.","date":"1996","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/8723352","citation_count":65,"is_preprint":false},{"pmid":"9233764","id":"PMC_9233764","title":"Inhibition of E2F-4/DP-1-stimulated transcription by p202.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9233764","citation_count":65,"is_preprint":false},{"pmid":"18504435","id":"PMC_18504435","title":"Rb/E2F4 and Smad2/3 link survivin to TGF-beta-induced apoptosis and tumor progression.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18504435","citation_count":64,"is_preprint":false},{"pmid":"8878551","id":"PMC_8878551","title":"Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability.","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8878551","citation_count":61,"is_preprint":false},{"pmid":"9485005","id":"PMC_9485005","title":"Close correlation between mutations of E2F4 and hMSH3 genes in colorectal cancers with microsatellite instability.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9485005","citation_count":61,"is_preprint":false},{"pmid":"31270324","id":"PMC_31270324","title":"E2F4 regulates transcriptional activation in mouse embryonic stem cells independently of the RB family.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31270324","citation_count":60,"is_preprint":false},{"pmid":"10454552","id":"PMC_10454552","title":"E2F4 actively promotes the initiation and maintenance of nerve growth factor-induced cell differentiation.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10454552","citation_count":56,"is_preprint":false},{"pmid":"17383628","id":"PMC_17383628","title":"E2f4 is required for normal development of the airway epithelium.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17383628","citation_count":56,"is_preprint":false},{"pmid":"35253629","id":"PMC_35253629","title":"Therapeutic targeting of the USP2-E2F4 axis inhibits autophagic machinery essential for zinc homeostasis in cancer progression.","date":"2022","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/35253629","citation_count":53,"is_preprint":false},{"pmid":"11005809","id":"PMC_11005809","title":"Opposite functions for E2F1 and E2F4 in human epidermal keratinocyte differentiation.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11005809","citation_count":50,"is_preprint":false},{"pmid":"17043659","id":"PMC_17043659","title":"E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17043659","citation_count":50,"is_preprint":false},{"pmid":"17957245","id":"PMC_17957245","title":"Cell cycle genes are the evolutionarily conserved targets of the E2F4 transcription factor.","date":"2007","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/17957245","citation_count":49,"is_preprint":false},{"pmid":"26825228","id":"PMC_26825228","title":"E2f4 and E2f5 are essential for the development of the male reproductive system.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26825228","citation_count":48,"is_preprint":false},{"pmid":"17121828","id":"PMC_17121828","title":"An antisense transcript induced by Wnt/beta-catenin signaling decreases E2F4.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17121828","citation_count":48,"is_preprint":false},{"pmid":"30047092","id":"PMC_30047092","title":"Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression.","date":"2018","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/30047092","citation_count":43,"is_preprint":false},{"pmid":"12604789","id":"PMC_12604789","title":"The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12604789","citation_count":42,"is_preprint":false},{"pmid":"26702562","id":"PMC_26702562","title":"Dietary myo-inositol modulates immunity through antioxidant activity and the Nrf2 and E2F4/cyclin signalling factors in the head kidney and spleen following infection of juvenile fish with Aeromonas hydrophila.","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26702562","citation_count":42,"is_preprint":false},{"pmid":"9537223","id":"PMC_9537223","title":"Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation.","date":"1998","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/9537223","citation_count":41,"is_preprint":false},{"pmid":"30120325","id":"PMC_30120325","title":"Multicilin and activated E2f4 induce multiciliated cell differentiation in primary fibroblasts.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30120325","citation_count":38,"is_preprint":false},{"pmid":"33166399","id":"PMC_33166399","title":"Benzo[a]pyrene represses DNA repair through altered E2F1/E2F4 function marking an early event in DNA damage-induced cellular senescence.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33166399","citation_count":38,"is_preprint":false},{"pmid":"35023014","id":"PMC_35023014","title":"Unveiling E2F4, TEAD1 and AP-1 as regulatory transcription factors of the replicative senescence program by multi-omics analysis.","date":"2022","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/35023014","citation_count":38,"is_preprint":false},{"pmid":"10208422","id":"PMC_10208422","title":"Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10208422","citation_count":38,"is_preprint":false},{"pmid":"10797289","id":"PMC_10797289","title":"Genomic structure and mutation screening of the E2F4 gene in human tumors.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10797289","citation_count":36,"is_preprint":false},{"pmid":"30841904","id":"PMC_30841904","title":"Overexpressing p130/E2F4 in mesenchymal stem cells facilitates the repair of injured alveolar epithelial cells in LPS-induced ARDS mice.","date":"2019","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/30841904","citation_count":36,"is_preprint":false},{"pmid":"32314545","id":"PMC_32314545","title":"LncRNA HAND2-AS1 represses cervical cancer progression by interaction with transcription factor E2F4 at the promoter of C16orf74.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32314545","citation_count":36,"is_preprint":false},{"pmid":"26782942","id":"PMC_26782942","title":"Characterization of the promoter region of the bovine long-chain acyl-CoA synthetase 1 gene: Roles of E2F1, Sp1, KLF15, and E2F4.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26782942","citation_count":36,"is_preprint":false},{"pmid":"32239565","id":"PMC_32239565","title":"Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32239565","citation_count":35,"is_preprint":false},{"pmid":"29581135","id":"PMC_29581135","title":"ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors.","date":"2018","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/29581135","citation_count":33,"is_preprint":false},{"pmid":"18368381","id":"PMC_18368381","title":"Transcription factor FBI-1 acts as a dual regulator in adipogenesis by coordinated regulation of cyclin-A and E2F-4.","date":"2008","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/18368381","citation_count":33,"is_preprint":false},{"pmid":"21311680","id":"PMC_21311680","title":"Curcumin Induces Downregulation of E2F4 Expression and Apoptotic Cell Death in HCT116 Human Colon Cancer Cells; Involvement of Reactive Oxygen Species.","date":"2010","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21311680","citation_count":32,"is_preprint":false},{"pmid":"11160943","id":"PMC_11160943","title":"A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11160943","citation_count":32,"is_preprint":false},{"pmid":"22586272","id":"PMC_22586272","title":"Nerve growth factor-induced cell cycle reentry in newborn neurons is triggered by p38MAPK-dependent E2F4 phosphorylation.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22586272","citation_count":32,"is_preprint":false},{"pmid":"17507799","id":"PMC_17507799","title":"E2F4 function in G2: maintaining G2-arrest to prevent mitotic entry with damaged DNA.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17507799","citation_count":31,"is_preprint":false},{"pmid":"16776654","id":"PMC_16776654","title":"Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16776654","citation_count":31,"is_preprint":false},{"pmid":"28842672","id":"PMC_28842672","title":"Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28842672","citation_count":31,"is_preprint":false},{"pmid":"15231644","id":"PMC_15231644","title":"Genotoxic stress induces expression of E2F4, leading to its association with p130 in prostate carcinoma cells.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15231644","citation_count":30,"is_preprint":false},{"pmid":"15040009","id":"PMC_15040009","title":"The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation.","date":"2004","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15040009","citation_count":29,"is_preprint":false},{"pmid":"30218642","id":"PMC_30218642","title":"Distinct requirements of E2f4 versus E2f5 activity for multiciliated cell development in the zebrafish embryo.","date":"2018","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/30218642","citation_count":29,"is_preprint":false},{"pmid":"15611646","id":"PMC_15611646","title":"E2F4 deficiency promotes drug-induced apoptosis.","date":"2004","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15611646","citation_count":28,"is_preprint":false},{"pmid":"19955219","id":"PMC_19955219","title":"E2F4 is required for cardiomyocyte proliferation.","date":"2009","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/19955219","citation_count":28,"is_preprint":false},{"pmid":"16633736","id":"PMC_16633736","title":"Host cell factor-1 and E2F4 interact via multiple determinants in each protein.","date":"2006","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16633736","citation_count":28,"is_preprint":false},{"pmid":"34335934","id":"PMC_34335934","title":"E2F4 Promotes the Proliferation of Hepatocellular Carcinoma Cells through Upregulation of CDCA3.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34335934","citation_count":28,"is_preprint":false},{"pmid":"19644500","id":"PMC_19644500","title":"ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4.","date":"2009","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/19644500","citation_count":28,"is_preprint":false},{"pmid":"10366563","id":"PMC_10366563","title":"Herpes simplex virus induces intracellular redistribution of E2F4 and accumulation of E2F pocket protein complexes.","date":"1999","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/10366563","citation_count":27,"is_preprint":false},{"pmid":"22985930","id":"PMC_22985930","title":"Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.","date":"2012","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/22985930","citation_count":27,"is_preprint":false},{"pmid":"28610850","id":"PMC_28610850","title":"Dietary myo-inositol deficiency decreased the growth performances and impaired intestinal physical barrier function partly relating to nrf2, jnk, e2f4 and mlck signaling in young grass carp (Ctenopharyngodon idella).","date":"2017","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28610850","citation_count":27,"is_preprint":false},{"pmid":"12754095","id":"PMC_12754095","title":"N-Acetylcysteine enhances UV-mediated caspase-3 activation, fragmentation of E2F-4, and apoptosis in human C8161 melanoma: inhibition by ectopic Bcl-2 expression.","date":"2003","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12754095","citation_count":27,"is_preprint":false},{"pmid":"11759817","id":"PMC_11759817","title":"Expression of E2F-1 and E2F-4 is reduced in primary and metastatic breast carcinomas.","date":"2001","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/11759817","citation_count":26,"is_preprint":false},{"pmid":"17537963","id":"PMC_17537963","title":"Cell cycle regulator E2F4 is essential for the development of the ventral telencephalon.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17537963","citation_count":26,"is_preprint":false},{"pmid":"31943751","id":"PMC_31943751","title":"E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31943751","citation_count":25,"is_preprint":false},{"pmid":"19585502","id":"PMC_19585502","title":"E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin.","date":"2009","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19585502","citation_count":25,"is_preprint":false},{"pmid":"24828495","id":"PMC_24828495","title":"Regulation of ischemic neuronal death by E2F4-p130 protein complexes.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24828495","citation_count":24,"is_preprint":false},{"pmid":"12055184","id":"PMC_12055184","title":"Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12055184","citation_count":24,"is_preprint":false},{"pmid":"31052266","id":"PMC_31052266","title":"Amino Acid Deprivation-Induced Autophagy Requires Upregulation of DIRAS3 through Reduction of E2F1 and E2F4 Transcriptional Repression.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31052266","citation_count":23,"is_preprint":false},{"pmid":"12655094","id":"PMC_12655094","title":"Stimulation of bovine herpesvirus-1 productive infection by the adenovirus E1A gene and a cell cycle regulatory gene, E2F-4.","date":"2003","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/12655094","citation_count":23,"is_preprint":false},{"pmid":"11896585","id":"PMC_11896585","title":"Differences in DNA binding properties between E2F1 and E2F4 specify repression of the Mcl-1 promoter.","date":"2002","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11896585","citation_count":22,"is_preprint":false},{"pmid":"16153605","id":"PMC_16153605","title":"Cell cycle-related transformation of the E2F4-p130 repressor complex.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16153605","citation_count":19,"is_preprint":false},{"pmid":"26032289","id":"PMC_26032289","title":"E2F4 Program Is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.","date":"2015","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/26032289","citation_count":18,"is_preprint":false},{"pmid":"11012981","id":"PMC_11012981","title":"Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach.","date":"2000","source":"Pathology international","url":"https://pubmed.ncbi.nlm.nih.gov/11012981","citation_count":18,"is_preprint":false},{"pmid":"34838479","id":"PMC_34838479","title":"E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis.","date":"2021","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/34838479","citation_count":17,"is_preprint":false},{"pmid":"9074408","id":"PMC_9074408","title":"The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4, DP-1 and p130.","date":"1997","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/9074408","citation_count":17,"is_preprint":false},{"pmid":"16505226","id":"PMC_16505226","title":"Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissue.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16505226","citation_count":16,"is_preprint":false},{"pmid":"23919615","id":"PMC_23919615","title":"ERK-associated changes in E2F4 phosphorylation, localization and transcriptional activity during mitogenic stimulation in human intestinal epithelial crypt cells.","date":"2013","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23919615","citation_count":16,"is_preprint":false},{"pmid":"12373148","id":"PMC_12373148","title":"Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study.","date":"2002","source":"Applied immunohistochemistry & molecular morphology : AIMM","url":"https://pubmed.ncbi.nlm.nih.gov/12373148","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50152,"output_tokens":9479,"usd":0.14632,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":19627,"output_tokens":6957,"usd":0.13603,"stage2_stop_reason":"end_turn"},"total_usd":0.28235,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"E2F4 associates with p107 in vivo (co-immunoprecipitation), requires DP-1 for efficient DNA binding and transcriptional activation of E2F site-containing promoters, and lacks nuclear localization signal leading to distinct subcellular distribution compared to E2F-1.\",\n      \"method\": \"Co-immunoprecipitation, transient transfection reporter assays, cell cycle analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and functional reporter assays independently replicated in two simultaneous papers (PMID:7958925 and PMID:7958924)\",\n      \"pmids\": [\"7958925\", \"7958924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"E2F4 forms heterodimers with DP family members, and p107 binding suppresses E2F4 transcriptional activity and its ability to transform immortalized rodent cells.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, focus-formation/transformation assays, reporter gene assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (two-hybrid, Co-IP, functional transformation assay) in two independent labs\",\n      \"pmids\": [\"7958924\", \"7958925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"E2F4 interacts with p130 in a yeast two-hybrid system and forms differentially phosphorylated complexes with p130 throughout the cell cycle; E2F4 is present throughout the cell cycle unlike E2F-1/-2/-3.\",\n      \"method\": \"Yeast two-hybrid, Co-immunoprecipitation, Western blot\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid plus Co-IP, confirmed in two independent simultaneous publications\",\n      \"pmids\": [\"7892279\", \"7705662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"p130 effectively suppresses E2F4-mediated transactivation, and coexpression of E2F4 overcomes p130-mediated G1 arrest more efficiently than RB-induced G1 blockade, revealing biochemically distinct mechanisms for p130 versus RB in cell cycle arrest.\",\n      \"method\": \"Transient transfection, reporter assays, cell cycle analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple functional assays with clear mechanistic distinction between p130 and RB pathways\",\n      \"pmids\": [\"7705662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"p130-E2F4 complexes occupy the cdc2 promoter at a non-canonical E2F site located at position -20 in quiescent cells (G0/G1), and release of this complex at S phase entry correlates with cdc2 induction; mutation of the -20 element de-represses cdc2 in quiescent cells.\",\n      \"method\": \"In vivo footprinting, Co-IP, transient transfection with promoter mutants\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo footprinting combined with promoter mutagenesis and functional reporter assays in a single rigorous study\",\n      \"pmids\": [\"8524257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"E2F4 switches pocket protein partners in a cell cycle-dependent manner: it is sequestered by p130 in arrested/quiescent cells but associates with both pRB and p107 as cells pass the G1-to-S transition; E2F4 accounts for the vast majority of endogenous E2F activity.\",\n      \"method\": \"Specific antisera immunoprecipitation, cell cycle fractionation, EMSA\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic cell-cycle fractionation with specific antisera, multiple cell-cycle stages analyzed\",\n      \"pmids\": [\"8657117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"During G1-to-G0 transition, p130 undergoes CDK-independent phosphorylation (form 2) that promotes p130-E2F4 complex formation characteristic of G0; subsequent CDK-mediated hyperphosphorylation (form 3) in mid-G1 dissociates E2F4 from p130.\",\n      \"method\": \"Cell cycle synchronization, Western blot, in vitro kinase assay with cyclin/CDK\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro CDK phosphorylation reconstitution combined with cell cycle biochemistry in one study\",\n      \"pmids\": [\"8710362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"E2F4 subcellular localization is cell cycle-dependent: it is predominantly cytoplasmic when ectopically expressed, but nuclear localization is induced by cotransfection of p107, p130, or DP-2 (but not DP-1); nuclear E2F4 shows markedly enhanced transcriptional activity, and endogenous E2F4 has high nuclear/cytoplasmic ratios in G0/early G1, shifting to more cytoplasmic as cells approach S phase.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, reporter assays, cell synchronization\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live-cell localization, fractionation, and functional reporter assays combined with cell cycle analysis\",\n      \"pmids\": [\"9144196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"E2F4 lacks a nuclear localization signal and requires cytoplasmic binding partners (p107, pRb2/p130, or the NLS-containing DP3δ isoform) to enter the nucleus; nuclear accumulation via p107 or p130 correlates with growth arrest, whereas E2F4/DP3δ-induced cell cycle reactivation is counteracted by p107 or p130 overexpression.\",\n      \"method\": \"Immunoprecipitation, subcellular fractionation, cotransfection, cell cycle analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic dissection of NLS requirement with multiple domain mutants and functional rescue experiments\",\n      \"pmids\": [\"9537223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"E2F4 is actively exported from the nucleus in a CRM1-dependent manner via two hydrophobic nuclear export sequences; mutation of both export signals prevents cytoplasmic localization, and CRM1 overexpression can prevent p16INK4a-induced cell cycle arrest (an E2F4-dependent process).\",\n      \"method\": \"Leptomycin B treatment, export sequence mutagenesis, CRM1 overexpression, cell cycle analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — pharmacological inhibition of export combined with mutagenesis of export signals and functional cell cycle readout\",\n      \"pmids\": [\"11158323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"E2F4 and E2F5 double knockout mouse embryonic fibroblasts fail to arrest in G1 in response to p16INK4a, demonstrating that E2F4 and E2F5 are dispensable for cell cycle progression per se but are necessary for pocket protein-mediated G1 arrest of cycling cells.\",\n      \"method\": \"Double knockout mouse model, MEF isolation, cell cycle analysis, p16INK4a challenge\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic double knockout with specific cellular phenotype and mechanistic pathway placement\",\n      \"pmids\": [\"11030352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Loss of E2F4 in mice causes a cell-autonomous defect in late-stage erythroid maturation and abnormalities in hematopoietic lineage development, as well as gut epithelial defects, indicating E2F4 controls the maturation of multiple cell lineages.\",\n      \"method\": \"Knockout mouse model, histopathology, bone marrow analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independently replicated by two separate knockout mouse studies in the same journal issue\",\n      \"pmids\": [\"10983976\", \"10983977\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p130/E2F4 complex binds and represses the cdc2 promoter via the R box (positions -22 to -2) in response to p53; this repression requires p21/WAF1, which inhibits CDK activity, thereby facilitating p130 dephosphorylation and p130/E2F4 binding.\",\n      \"method\": \"Promoter reporter assays, EMSA, Co-IP, p21 antisense experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA, reporter assay, and genetic p21 requirement tested with multiple orthogonal approaches\",\n      \"pmids\": [\"11032828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A preformed cytoplasmic complex containing Smad3, E2F4/5, DP1, and the corepressor p107 translocates to the nucleus in response to TGF-β, associates with Smad4, and binds a composite Smad-E2F site on the c-myc promoter to repress c-myc transcription.\",\n      \"method\": \"Co-immunoprecipitation, subcellular fractionation, ChIP, reporter assays, dominant-negative experiments\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (Co-IP, ChIP, fractionation, reporter assays) in one rigorous study with high impact\",\n      \"pmids\": [\"12150994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"E2F4 loss suppresses pituitary and thyroid tumor development in Rb+/- mice and suppresses inappropriate proliferation of pRB-deficient cells; biochemical analysis indicates this occurs because E2F4 loss allows p107 and p130 to regulate the pRB-specific activator E2Fs.\",\n      \"method\": \"Compound knockout mouse model, tumor monitoring, Western blot, cell proliferation assays\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis with biochemical mechanistic follow-up\",\n      \"pmids\": [\"12498715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p130 requires at least nine phosphorylation sites (three Cdk4/6-specific plus six additional serines: S413, S639, S662, S1044, S1080, S1112) for full regulation of E2F4 activity and cell cycle control; p107 regulation of E2F4 requires its three Cdk4/6-specific sites only.\",\n      \"method\": \"Alanine substitution mutagenesis, E2F reporter assays, cell cycle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic in vitro mutagenesis combined with functional reporter and cell cycle assays\",\n      \"pmids\": [\"12006580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes occupy the ER-alpha promoter in vivo in ER-negative breast cancer cells, mediating transcriptional repression of ER-alpha.\",\n      \"method\": \"ChIP, Co-IP, in vivo promoter occupancy analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP in cell lines, single lab, two orthogonal methods\",\n      \"pmids\": [\"12789259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The p16INK4a-RB pathway is blocked by EBV LMP1 in part through CRM1-dependent nuclear export of E2F4/5, preventing E2F4/5 from mediating p16INK4a-induced cell cycle arrest.\",\n      \"method\": \"Subcellular fractionation, leptomycin B treatment, cell cycle analysis, reporter assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition of CRM1 plus localization and functional assays\",\n      \"pmids\": [\"12860972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"E2F4 loss in mice prevents spontaneous adipocyte differentiation independently of changes in E2F-responsive gene expression or cell cycle regulation, and this anti-adipogenic function of E2F4 operates independently of its interaction with pocket proteins.\",\n      \"method\": \"Compound knockout MEF differentiation assays, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection in compound mutant MEFs separating cell cycle function from differentiation function\",\n      \"pmids\": [\"12604789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ionizing radiation increases E2F4 protein levels and promotes E2F4 nuclear accumulation and binding to p130 (but not p107) in prostate carcinoma cells via p130 dephosphorylation and dissociation from CDK2; siRNA knockdown of E2F4 prevents E2F4/p130 complex formation and sensitizes cells to radiation-induced apoptosis.\",\n      \"method\": \"Western blot, nuclear fractionation, Co-IP, siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA loss-of-function with specific apoptotic phenotype and mechanistic Co-IP, single lab\",\n      \"pmids\": [\"15231644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"E2f4 promotes fetal erythroid proliferation by directly activating cell cycle control genes; loss of E2f4 results in impaired cell cycle progression and decreased erythroid proliferation, causing macrocytic anemia.\",\n      \"method\": \"E2f4 knockout mouse model, cDNA microarray, cell cycle analysis, BrdU incorporation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout mouse with microarray identification of direct targets and cell cycle phenotype\",\n      \"pmids\": [\"16861343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Following radiation treatment, E2F4 colocalizes with p130 in the nucleus during G2-phase arrest and represses mitotic genes (Bub3, Pttg1) as identified by ChIP; siRNA knockdown of E2F4 sensitizes cells to radiation-induced DNA damage and cell death.\",\n      \"method\": \"Immunofluorescence, ChIP, siRNA knockdown, microarray, clonogenic survival assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter occupancy combined with siRNA loss-of-function and functional survival assay\",\n      \"pmids\": [\"17043659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Host Cell Factor-1 (HCF-1) directly interacts with E2F4 via multiple determinants: E2F4 targets both the kelch domain (through its HBM tetrapeptide DHXY motif) and the basic domain of HCF-1; HCF-1 co-activates E2F4/DP-1 transcriptional activity.\",\n      \"method\": \"GST pulldown, Co-IP, mutagenesis, transient transfection reporter assays, temperature-sensitive HCF-1 rescue assay\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding confirmed by pulldown and Co-IP with mutagenesis, single lab\",\n      \"pmids\": [\"16633736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The mammalian DREAM complex contains p130 and E2F4 (along with LIN-9, LIN-37, LIN-52, LIN-54, RBBP4) and binds to more than 800 human promoters in G0 to repress cell cycle-dependent genes; in S phase, MuvB proteins dissociate from p130 and form a distinct submodule with MYB.\",\n      \"method\": \"Affinity purification/mass spectrometry, ChIP-chip, RNAi knockdown, genome-wide promoter analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — proteomics-based complex identification combined with genome-wide ChIP-chip and functional RNAi in one integrated study\",\n      \"pmids\": [\"17531812\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Mip/LIN-9 forms a repressor complex with E2F4 and p107 or p130 in G0/early G1; phosphorylation of pocket proteins by CDK4 drives dissociation of Mip/LIN-9 from E2F4/p107/p130; expression of p107 blocks B-Myb/Mip/LIN-9-induced activation of the cyclin B promoter.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, cell cycle synchronization, CDK4 overexpression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and functional reporter assays, single lab\",\n      \"pmids\": [\"17563750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"E2f4 deficiency in mice leads to complete absence of ciliated cells from the airway epithelium and nasal sinuses, replaced by columnar secretory cells, and reduced Clara cell marker expression, demonstrating a cell-cycle-independent requirement of E2f4 in determining airway epithelial cell fate.\",\n      \"method\": \"E2f4 knockout mouse model, histology, immunohistochemistry, BrdU cell proliferation analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — well-characterized knockout phenotype with cell-proliferation controls ruling out indirect effects\",\n      \"pmids\": [\"17383628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"E2F4 deficiency in mice results in loss of ventral telencephalic structures and impaired neural precursor self-renewal associated with dramatic reduction in Shh expression; genetic interaction between E2F4 and Shh pathways was confirmed by compound heterozygous crosses and Hh agonist rescue.\",\n      \"method\": \"Knockout mouse model, genetic epistasis (compound heterozygous cross), Shh enhancer reporter assay, Hh agonist rescue\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic epistasis plus functional enhancer assay and pharmacological rescue\",\n      \"pmids\": [\"17537963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TGF-β suppresses survivin expression in prostate epithelial cells via Smad2/3-dependent hypophosphorylation of Rb, which enables Rb/E2F4 repressor complexes to bind CDE/CHR repressor elements in the survivin promoter.\",\n      \"method\": \"Co-IP, ChIP, promoter reporter assays, viral overexpression/silencing of survivin\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with functional gene delivery experiments, single lab\",\n      \"pmids\": [\"18504435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"ARF disrupts the interaction between E2F4 and DP1, reducing occupancy of the E2F4-p130 repressor complex at the XPC promoter, thereby increasing XPC expression and enabling nucleotide excision repair; cells lacking ARF are NER-deficient and ARF expression restores repair.\",\n      \"method\": \"Co-IP, ChIP, genetic ARF knockout cells, NER functional assay\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and genetic loss-of-function with functional DNA repair readout\",\n      \"pmids\": [\"19644500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"E2F4 nuclear localization in intestinal cells is proliferation-dependent; cytoplasmic retention and sequestration by Rb proteins represent critical steps in cell cycle exit; inhibition of p38 MAP kinase induces E2F4 nuclear translocation and transcriptional activity.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, Ki67 co-staining, p38 inhibitor treatment\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway interrogation combined with localization and functional assays, single lab\",\n      \"pmids\": [\"15040009\", \"19562678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PARP inhibition causes increased occupancy of BRCA1 and RAD51 promoters by repressive E2F4/p130 complexes, leading to suppression of HDR; disruption of p130 by HPV E7 expression or siRNA knockdown reverses both the transcriptional repression and the cytotoxicity.\",\n      \"method\": \"ChIP, siRNA knockdown, GFP-based HDR assay, clonogenic survival\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP demonstrating direct promoter occupancy combined with genetic disruption of p130 and functional HDR assay\",\n      \"pmids\": [\"20133863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"E2F4 binding sites are present both near transcription start sites and at distal enhancer-like elements (>20 kb from annotated TSS); overexpression of E2F4 with RB family members and DP-1 reveals that E2F4 can act as both a transcriptional activator and a repressor.\",\n      \"method\": \"ChIP-seq, overexpression studies, functional reporter assays\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq combined with overexpression functional assays, single lab\",\n      \"pmids\": [\"21247883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p27Kip1 directly interacts with p130 and E2F4 through its carboxy-half (demonstrated by affinity chromatography), is recruited to target promoters by p130, and is required for subsequent recruitment of HDAC and mSin3A to repress transcription.\",\n      \"method\": \"Co-IP, affinity chromatography, ChIP, luciferase reporter assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding by affinity chromatography plus ChIP, single lab\",\n      \"pmids\": [\"22179826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KDM5A (H3K4 demethylase) co-occupies E2F4 target gene promoters; during ES cell differentiation, KDM5A and E2F4 cooperate to repress cell cycle genes, with p130 (DREAM component) also binding these targets in terminally differentiated cells; KDM5A is recruited independently of E2F4 but cooperates with E2F4 for deepened repression.\",\n      \"method\": \"ChIP-seq, KDM5A knockout ES cells, ChIP, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq combined with genetic knockout and functional differentiation experiments\",\n      \"pmids\": [\"23093672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"E2F4-p130 repressor complex directly represses transcription of apoptosis-related genes (E2F1, Apaf-1, p73α) in cardiomyocytes through HDAC1 recruitment; loss of E2F4 in vivo leads to enhanced cardiomyocyte apoptosis; HDAC-binding deficient p130 or kinase-dead HDAC1 mutants abolish the anti-apoptotic function.\",\n      \"method\": \"ChIP, E2F4 knockout mouse histology, dominant-negative HDAC1/p130 mutants, hypoxia apoptosis assay\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP combined with genetic knockout in vivo and domain-specific mutant functional assays\",\n      \"pmids\": [\"22985930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"p38MAPK phosphorylates E2F4 at Thr261/Thr263 residues in differentiating chick retinal neurons downstream of NGF/p75NTR signaling; phosphorylated E2F4 is recruited to the E2F-responsive cdc2 promoter to trigger cell cycle reentry and apoptosis; constitutively active E2F4-T261E/T263E mimics this, while dominant-negative T261A/T263A blocks NGF-induced reactivation.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antibody, ChIP, constitutively active and dominant-negative E2F4 mutants, cell cycle analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro kinase assay combined with phospho-mutagenesis and ChIP demonstrating promoter recruitment\",\n      \"pmids\": [\"22586272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"p53-mediated repression of target genes (survivin, CDC25C, CDC25B) is mediated through p21-dependent recruitment of E2F4 repressor complexes to promoters; inactivation of RB pocket proteins (not RB alone) prevents E2F4 recruitment and gene repression; E2F4 promoter occupancy globally marks p53-repression targets but not p53-activation targets.\",\n      \"method\": \"ChIP, siRNA knockdown of pocket proteins, ChIP-seq integration, reporter assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP with genome-wide integration, genetic dissection of pocket protein requirement, multiple target genes validated\",\n      \"pmids\": [\"24096481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MEK/ERK activation and GSK3 inhibition are both required for E2F4 phosphorylation, nuclear translocation, and G1/S phase entry in human intestinal epithelial cells; EGF activates ERK but fails to promote E2F4 nuclear translocation unless GSK3 is concomitantly inhibited.\",\n      \"method\": \"MEK inhibitor (U0126), GSK3 inhibitor (SB216763), phosphorylation analysis, immunofluorescence, cell cycle analysis\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological pathway dissection with multiple inhibitor combinations and localization readout, single lab\",\n      \"pmids\": [\"23919615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"E2F4 plays a protective role in neurons against ischemia/DNA damage by forming repressive complexes at the B-Myb promoter under basal conditions; following stress, E2F4-p130 complexes are lost from B-Myb promoter sites, B-Myb expression increases, and neuronal death ensues.\",\n      \"method\": \"ChIP, Co-IP, in vitro ischemia/hypoxia models, in vivo global ischemia model, E2F4 gain/loss-of-function\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating direct promoter occupancy combined with in vivo genetic and in vitro functional assays, single lab\",\n      \"pmids\": [\"24828495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"E2F4-RBL2(p130)-HDAC1-BRM(SWI/SNF) repressor complex assembles at the PARP1 promoter during differentiation-associated cell cycle exit, deacetylating nucleosomes and compacting chromatin to silence PARP1; HDAC inhibition restores PARP1 expression without disrupting complex-chromatin interaction.\",\n      \"method\": \"ChIP, Co-IP, HDAC inhibitor treatment, siRNA knockdown, chromatin accessibility analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with pharmacological and genetic perturbations, single lab\",\n      \"pmids\": [\"28842672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Multicilin transcriptional activity in multiciliated cell (MCC) differentiation requires E2F4 as a co-activator; a fusion of E2F4 with the VP16 activation domain (E2F4VP16) in combination with Multicilin is sufficient to bypass the transcriptional block in primary fibroblasts and drive massive centriole expansion via the deuterosome pathway.\",\n      \"method\": \"Adenoviral overexpression in primary MEFs, centriole expansion quantification, temporal organelle biogenesis analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with activation domain fusion in non-natural cell type, single lab\",\n      \"pmids\": [\"30120325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In mouse embryonic stem cells, E2F4 acts as a transcriptional activator of cell cycle genes independently of the RB family; E2F4 functionally interacts with chromatin regulators associated with gene activation, and loss of E2F4 in RB family-mutant cells decreases histone acetylation at E2F target gene promoters.\",\n      \"method\": \"E2F4 knockout in RB family triple-mutant ESCs, ChIP for histone acetylation, RNA-seq, proliferation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function in genetically defined RB-null background with epigenomic and transcriptomic readouts\",\n      \"pmids\": [\"31270324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP2 deubiquitinase stabilizes E2F4 protein through physical interaction and deubiquitination; stabilized E2F4 directly activates transcription of autophagy genes ATG2A and ULK2 to drive cytoprotective autophagy and zinc homeostasis in gastric cancer cells.\",\n      \"method\": \"Co-IP, GST pulldown, CHX chase/ubiquitination assays, ChIP, gain/loss-of-function studies, in vivo xenograft\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — deubiquitination biochemistry (Co-IP, ubiquitin assay, CHX chase) combined with ChIP of direct target promoters and in vivo rescue experiments\",\n      \"pmids\": [\"35253629\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"E2F4 is a transcription factor that lacks an intrinsic nuclear localization signal and shuttles between cytoplasm and nucleus in a cell cycle-dependent manner: in quiescent cells it is imported into the nucleus by binding to p130 (or p107/DP-2), where it forms multiprotein repressor complexes (including DREAM, which contains p130, LIN-9/37/52/54, and RBBP4) that silence hundreds of cell cycle-dependent target gene promoters; upon mitogenic stimulation, CDK-mediated hyperphosphorylation of p130/p107 dissociates these complexes, and E2F4 is actively exported from the nucleus via CRM1-dependent hydrophobic export sequences; beyond canonical G1 repression, E2F4/p130 complexes also maintain a stable G2 arrest in response to genotoxic stress by repressing mitotic genes, and E2F4 can act as a transcriptional activator of cell cycle genes in certain contexts (e.g., embryonic stem cells) independently of the RB family; post-translational regulation includes deubiquitination and stabilization by USP2, and phosphorylation by p38MAPK at Thr261/263 that promotes its recruitment to specific promoters; E2F4 also functions as a downstream effector of TGF-β signaling through a preformed cytoplasmic complex with Smad3/E2F4/DP1/p107 that translocates to the nucleus to repress c-myc.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"E2F4 is a DP-heterodimerizing transcription factor that serves as the principal effector of pocket-protein-mediated transcriptional repression, silencing cell cycle-dependent genes in quiescent and arrested cells and accounting for the majority of endogenous E2F DNA-binding activity [#0, #1, #5]. E2F4 lacks an intrinsic nuclear localization signal and depends on cytoplasmic binding to pocket proteins p130, p107, or pRB (or the NLS-bearing DP3\\u03b4 isoform) for nuclear entry, where partner choice is cell cycle-dependent: p130 sequesters E2F4 in quiescence and is exchanged for pRB/p107 across the G1/S transition [#5, #7, #8]. Nuclear residence is opposed by CRM1-dependent export through two hydrophobic export sequences, and CDK-driven hyperphosphorylation of p130/p107 dissociates the repressor complexes to permit S-phase gene induction [#6, #9, #15]. In G0, E2F4/p130 nucleates the DREAM complex (with LIN-9/37/52/54 and RBBP4) that occupies more than 800 promoters, and assembles HDAC1-, mSin3A-, KDM5A-, and SWI/SNF-containing co-repressor modules that deacetylate and compact chromatin at target promoters such as cdc2, PARP1, and ER-alpha [#23, #16, #32, #33, #39]. E2F4/p130 repression is integrated into multiple arrest and stress pathways: it executes p53/p21-dependent gene silencing, maintains genotoxic G2 arrest by repressing mitotic genes, suppresses BRCA1/RAD51 to limit homologous-directed repair, and functions downstream of TGF-\\u03b2 via a preformed cytoplasmic Smad3/E2F4/DP1/p107 complex that represses c-myc [#12, #36, #21, #30, #13]. Genetically, E2F4 is dispensable for cell cycle progression itself but required for pocket-protein-mediated G1 arrest, and in vivo it controls maturation of erythroid, intestinal, airway-ciliated, and neural lineages, partly through cell-cycle-independent functions [#10, #11, #20, #25, #26]. In RB-family-null embryonic stem cells E2F4 instead acts as a direct transcriptional activator of cell cycle genes, and post-translational inputs\\u2014USP2-mediated deubiquitination/stabilization and p38MAPK phosphorylation at Thr261/263\\u2014redirect E2F4 toward activation of autophagy or cell-cycle-reentry programs [#41, #42, #35].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Established E2F4 as a DP-dependent E2F-family transcription factor whose activity is constrained by the pocket protein p107, defining its core biochemical identity.\",\n      \"evidence\": \"Co-IP, yeast two-hybrid, reporter and focus-formation/transformation assays in rodent cells\",\n      \"pmids\": [\"7958925\", \"7958924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the in vivo target gene set\", \"NLS deficiency noted but mechanism of nuclear entry unresolved\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Identified p130 as a cell-cycle-stage-specific E2F4 partner and showed p130 represses E2F4 transactivation through a mechanism biochemically distinct from RB, positioning E2F4/p130 at quiescence.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, in vivo footprinting and promoter mutagenesis at the cdc2 promoter\",\n      \"pmids\": [\"7892279\", \"7705662\", \"8524257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target scope unknown\", \"Phosphorylation sites controlling complex assembly not yet defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Showed E2F4 switches pocket-protein partners across the cell cycle and that p130 phosphorylation state governs complex assembly and dissociation, explaining temporal control of repression.\",\n      \"evidence\": \"Cell-cycle fractionation with specific antisera, EMSA, in vitro CDK kinase assays\",\n      \"pmids\": [\"8657117\", \"8710362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise p130 phosphosite requirements only later mapped\", \"Did not address subcellular trafficking\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Resolved how an NLS-less transcription factor reaches the nucleus, showing E2F4 is imported as a passenger of pocket proteins or the NLS-containing DP3\\u03b4 isoform, coupling localization to growth arrest.\",\n      \"evidence\": \"Immunofluorescence, subcellular fractionation, cotransfection and cell-cycle analysis\",\n      \"pmids\": [\"9144196\", \"9537223\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of nuclear exit not yet defined\", \"Endogenous stoichiometry of import partners unclear\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined CRM1-dependent nuclear export via hydrophobic export signals as the counterbalance to partner-mediated import, and used genetics to show E2F4/E2F5 are required specifically for pocket-protein-mediated G1 arrest rather than cycling.\",\n      \"evidence\": \"Leptomycin B, export-signal mutagenesis, CRM1 overexpression, and E2F4/E2F5 double-knockout MEFs challenged with p16INK4a\",\n      \"pmids\": [\"11158323\", \"11030352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals that trigger export switching not fully mapped\", \"Redundancy with E2F5 obscures E2F4-specific roles\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Connected E2F4/p130 repression to the p53/p21 tumor-suppressor axis and revealed cell-autonomous developmental roles in hematopoietic, erythroid, and gut lineages.\",\n      \"evidence\": \"EMSA, reporter assays, p21 antisense, and knockout-mouse histopathology\",\n      \"pmids\": [\"11032828\", \"10983976\", \"10983977\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect developmental targets not separated\", \"Tissue-specific cofactors undefined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed E2F4 downstream of TGF-\\u03b2 via a preformed cytoplasmic Smad3/E2F4/DP1/p107 complex repressing c-myc, and established in vivo genetic epistasis showing E2F4 loss suppresses Rb-deficient tumorigenesis by freeing p107/p130 to regulate activator E2Fs.\",\n      \"evidence\": \"Co-IP, fractionation, ChIP, reporter assays, and Rb+/-;E2f4-/- compound mouse tumor models\",\n      \"pmids\": [\"12150994\", \"12498715\", \"12006580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generality of Smad-E2F coupling across TGF-\\u03b2 targets unclear\", \"p130 phosphosite hierarchy tested in reporters not endogenous loci\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined the chromatin-modifying machinery recruited by E2F4 repressor complexes (HDAC1, SUV39H1, DNMT1, p300) at the ER-alpha promoter and identified additional regulatory inputs through CRM1-dependent export hijacked by EBV LMP1.\",\n      \"evidence\": \"ChIP, Co-IP of multimolecular complexes, and viral oncoprotein/leptomycin B perturbation\",\n      \"pmids\": [\"12789259\", \"12860972\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"ER-alpha complex composition from a single cell-line study\", \"Direct vs cooperative recruitment of each modifier not dissected\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated a pocket-protein-independent, cell-cycle-independent role for E2F4 in adipocyte differentiation, separating its differentiation functions from its canonical repressor activity.\",\n      \"evidence\": \"Compound-knockout MEF differentiation and gene-expression assays\",\n      \"pmids\": [\"12604789\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular partner mediating the pocket-protein-independent function unidentified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed E2F4/p130 enforces a stable post-genotoxic G2 arrest by repressing mitotic genes and confirmed direct HCF-1 binding as a transcriptional co-activator input, while a knockout study revealed E2F4 directly activates cell cycle genes to drive fetal erythroid proliferation.\",\n      \"evidence\": \"ChIP, immunofluorescence, siRNA and clonogenic survival; GST pulldown/Co-IP for HCF-1; knockout-mouse microarray and BrdU\",\n      \"pmids\": [\"17043659\", \"16633736\", \"16861343\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How E2F4 toggles between repressor and activator at the same loci unclear\", \"HCF-1 study single lab\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the DREAM complex at the molecular and genome-wide level, establishing E2F4/p130 with the MuvB module as the master quiescence repressor of >800 promoters, and extended E2F4 to cell-fate decisions in airway ciliated cells and ventral telencephalon via Shh.\",\n      \"evidence\": \"Affinity-purification/MS, ChIP-chip, RNAi; Co-IP for LIN-9; knockout-mouse histology and genetic Shh epistasis with agonist rescue\",\n      \"pmids\": [\"17531812\", \"17563750\", \"17383628\", \"17537963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking E2F4 to Shh transcription not fully resolved\", \"Determinants of MuvB-to-MYB submodule switching incomplete\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked E2F4/p130 repression to DNA repair regulation (XPC, NER) controlled by ARF disruption of the E2F4-DP1 interaction, and tied E2F4 nuclear localization in intestine to proliferation and p38 MAPK signaling.\",\n      \"evidence\": \"Co-IP, ChIP, ARF-knockout cells, NER assay; fractionation, Ki67 co-staining, p38 inhibition\",\n      \"pmids\": [\"19644500\", \"15040009\", \"19562678\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ARF accesses the E2F4-DP1 interface mechanistically undefined\", \"Intestinal p38 study single lab/Medium confidence\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrated that E2F4/p130 represses homologous-recombination genes (BRCA1, RAD51), making the complex a determinant of PARP-inhibitor cytotoxicity.\",\n      \"evidence\": \"ChIP, siRNA, HPV E7 disruption of p130, GFP-HDR assay and clonogenic survival\",\n      \"pmids\": [\"20133863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal coupling PARP inhibition to increased E2F4/p130 occupancy unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genome-wide mapping placed E2F4 at both promoters and distal enhancers and confirmed it can function as activator or repressor depending on cofactor context.\",\n      \"evidence\": \"ChIP-seq and overexpression reporter assays\",\n      \"pmids\": [\"21247883\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context determinants of activation vs repression not defined\", \"Single-lab genome-wide dataset\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified KDM5A as a cooperating repressor at E2F4 targets during ES differentiation and showed E2F4/p130-HDAC1 directly represses pro-apoptotic genes in cardiomyocytes, defining tissue-specific cytoprotective repression.\",\n      \"evidence\": \"ChIP-seq with KDM5A knockout ESCs; ChIP, E2F4-knockout mouse heart, dominant-negative HDAC1/p130 mutants, hypoxia apoptosis\",\n      \"pmids\": [\"23093672\", \"22985930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether KDM5A and DREAM act sequentially or cooperatively unresolved\", \"Cardiac target-gene generality limited\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed p38MAPK phosphorylation of E2F4 at Thr261/263 converts it into a promoter-recruited driver of cell cycle reentry and apoptosis in differentiating neurons, defining a phosphorylation switch in E2F4 function.\",\n      \"evidence\": \"In vitro kinase assay, phospho-specific antibody, ChIP, phospho-mimetic/dead E2F4 mutants\",\n      \"pmids\": [\"22586272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Thr261/263 phosphorylation operates outside neuronal context untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that p53/p21-dependent gene repression globally requires recruitment of E2F4 repressor complexes via pocket proteins, marking E2F4 occupancy as a signature of p53-repressed targets.\",\n      \"evidence\": \"ChIP, siRNA of pocket proteins, ChIP-seq integration, reporter assays; plus MEK/ERK+GSK3 control of E2F4 nuclear entry\",\n      \"pmids\": [\"24096481\", \"23919615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How p21-CDK inhibition selects specific E2F4 targets unclear\", \"MEK/ERK-GSK3 study single lab/Medium confidence\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended E2F4/p130 repression to neuroprotection through basal silencing of B-Myb, with stress-induced loss of occupancy driving neuronal death.\",\n      \"evidence\": \"ChIP, Co-IP, in vitro and in vivo ischemia models with E2F4 gain/loss-of-function\",\n      \"pmids\": [\"24828495\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Signal triggering complex eviction from B-Myb undefined\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined an E2F4-RBL2-HDAC1-BRM(SWI/SNF) complex that compacts chromatin to silence PARP1 during differentiation-associated cell cycle exit, detailing the chromatin-remodeling arm of repression.\",\n      \"evidence\": \"ChIP, Co-IP, HDAC inhibitor, siRNA, chromatin-accessibility analysis\",\n      \"pmids\": [\"28842672\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Order of HDAC vs SWI/SNF recruitment unresolved\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified E2F4 as a required co-activator for Multicilin-driven multiciliated-cell differentiation and centriole amplification, reinforcing an activator role in organelle biogenesis.\",\n      \"evidence\": \"Adenoviral E2F4 and E2F4-VP16 overexpression in primary fibroblasts with centriole quantification\",\n      \"pmids\": [\"30120325\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Endogenous activator mechanism vs VP16 fusion artifact not separated\", \"Single-lab gain-of-function\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated in RB-family-null ESCs that E2F4 directly activates cell cycle genes and increases histone acetylation at their promoters, formally establishing an RB-independent activator function.\",\n      \"evidence\": \"E2F4 knockout in RB triple-mutant ESCs with ChIP for acetylation, RNA-seq, proliferation assays\",\n      \"pmids\": [\"31270324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of activating chromatin partners not fully resolved\", \"Whether this occurs in RB-proficient cells unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed USP2 deubiquitinates and stabilizes E2F4, redirecting it to directly activate autophagy genes (ATG2A, ULK2) for cytoprotective autophagy in gastric cancer, linking E2F4 turnover to an activator output.\",\n      \"evidence\": \"Co-IP, GST pulldown, CHX chase/ubiquitination, ChIP, gain/loss-of-function, xenograft\",\n      \"pmids\": [\"35253629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase opposing USP2 on E2F4 unidentified\", \"Whether autophagy activation generalizes beyond gastric cancer untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How E2F4 is selectively switched between its dominant repressor mode and context-specific activator mode at individual loci, and which cofactors and post-translational modifications dictate that choice, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating phosphorylation, ubiquitination, and cofactor identity in choosing activation vs repression\", \"Activator partners largely uncharacterized relative to the well-defined repressor machinery\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 23, 41]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4, 31]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [13, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 8, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 8, 13]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [23, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [5, 10, 23]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [13, 23, 36]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 33, 39]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [13, 27]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [28, 30]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [42]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [11, 25, 26, 20]}\n    ],\n    \"complexes\": [\"DREAM complex\", \"Smad3/E2F4/DP1/p107 complex\", \"E2F4-RBL2-HDAC1-BRM(SWI/SNF) complex\"],\n    \"partners\": [\"TFDP1\", \"RBL2\", \"RBL1\", \"RB1\", \"LIN9\", \"SMAD3\", \"USP2\", \"HDAC1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}